The stability and efficacy of the drug nanocarriers greatly influence how well targeted drug delivery systems operate. By increasing their bioavailability, reducing their adverse effects, and allowing clinicians to specifically target diseased areas, these nanocarriers offer promise as a means of improving the therapeutic efficacy of medications. Many factors, however, influence the safety and efficacy of pharmacological nanocarriers: particle size, surface charge, chemical composition, ambient circumstances, and interactions with biological systems. Predictive analytics is being used to simulate these complex interactions and identify optimal approaches to make medical nanocarriers appear and function. This work investigates how effective medicine nanocarriers' safety may be tested using predictive analytics. Combining data from lab testing, computer models, and real-time tracking devices helps predictive models made to forecast how nanocarriers would behave in diverse contexts to make sense. Deep learning approaches, classification models, and regression analysis among other machine learning techniques enable the identification of the most crucial elements influencing the security of nanocarriers. These elements comprise their rate of breakdown, their propensity to cluster together, and their speed of drug release. The paper also addresses how artificial intelligence (AI) can enable improved prediction performance of these models. Using data from in vitro and in vivo investigations allows the models to be continuously refined to reflect how nanocarriers act in live entities undergoing change over time. This approach is more reliable and efficient in producing stable, well-performing nanocarriers that would be more valuable in medicine as it guarantees. The results of the study indicate that by providing important information regarding their safety, performance, and healing potential, predictive analytics might hasten the synthesis of therapeutic nanocarriers. Long term, this might result in improved and more efficient methods of providing medications for several disorders, including cancer, autoimmune diseases, and infectious diseases.
Keywords: Drug Nanocarriers, Predictive Analytics, Stability, Performance, Targeted Drug Delivery
How to cite this article: Bansal B, Jadhav T, Majumder R, Rane SR, Masurkar S, Ruikar SS, Predictive Analytics for Stability and Performance of Drug Nanocarriers .Int J Drug Deliv Technol. 2026;16(1s): 67-74; DOI: 10.25258/ijddt.16. 67-74